Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo. (Q53190873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

oral squamous cell carcinoma

20 January 2020

main subject

NF-κB

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Hiroyuki Furuta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kenji Osawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Masashi Shin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ayataka Ishikawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kou Matsuo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Masud Khan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Keiichi Ohya

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Masato Okamoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kazuhiro Tominaga

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Tetsu Takahashi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Osamu Nakanishi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Eijiro Jimi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

23 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

E625-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22262470%20AND%20SRC:MED&resulttype=core&format=json

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer

20 January 2020

cites work

1 reference

Molecular therapy in head and neck oncology

21 January 2018

1 reference

The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma

21 January 2018

1 reference

21 January 2018

1 reference

Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells

21 January 2018

1 reference

RANKL and RANK as novel therapeutic targets for arthritis

21 January 2018

1 reference

Osteoclast differentiation and activation

21 January 2018

1 reference

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

Regulation and function of NF-kappaB transcription factors in the immune system

21 January 2018

1 reference

NF-κB, inflammation, and metabolic disease.

21 January 2018

1 reference

NF-kappaB in solid tumors.

21 January 2018

1 reference

Nuclear factor-kappaB and liver carcinogenesis

21 January 2018

1 reference

Inflammation meets cancer, with NF-κB as the matchmaker

21 January 2018

1 reference

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.

21 January 2018

1 reference

Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.

21 January 2018

1 reference

The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma

21 January 2018

1 reference

Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression.

21 January 2018

1 reference

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

21 January 2018

1 reference

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

21 January 2018

1 reference

Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice

21 January 2018

1 reference

Association of cathepsin E with tumor growth arrest through angiogenesis inhibition and enhanced immune responses

21 January 2018

1 reference

IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide

21 January 2018

1 reference

Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway

21 January 2018

1 reference

Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway

21 January 2018

1 reference

The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells

21 January 2018

1 reference

Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts

21 January 2018

1 reference

NF-kappaB and cancer-identifying targets and mechanisms

21 January 2018

1 reference